About Leydig cell hypoplasia due to complete LH resistance
Leydig cell hypoplasia due to complete LH resistance is a rare disease catalogued by Orphanet (ORPHA:96265). It is associated with the LHCGR gene. Search below for active recruiting clinical trials from ClinicalTrials.gov, or visit the Orphanet expert page for specialist centres, natural history studies, and patient registries.
Clinical Trial Eligibility Tips
What to know before applying to Leydig cell hypoplasia due to complete LH resistance trials.
Search ClinicalTrials.gov for "Leydig cell hypoplasia due to complete LH resistance" or filter by Orphanet code ORPHA:96265 to find disease-specific studies.
Ask your specialist to refer you to a Centre of Expertise — Orphanet lists all accredited centres for this condition worldwide.
Natural history studies and patient registries often enrol before drug trials open — contact the Orphanet patient community first.
Patient Resources
Find recruiting Leydig cell hypoplasia due to complete LH resistance trials
Search 500,000+ studies from ClinicalTrials.gov, filtered for Leydig cell hypoplasia due to complete LH resistance. Updated daily.